Matrix Laboratories (Xiamen) Ltd
⚠️ Moderate Risk
FEI: 3003409823 • Xiamen, Fujian • CHINA
FEI Number
3003409823
Location
Xiamen, Fujian
Country
CHINAAddress
6 Yangtai Road, Zone, Haicang, Xiamen, Fujian, China
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NEW VET DR
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 6/19/2008 | 62GOS37FLUNIXIN MEGLUMINE (ANTI-INFLAMMATORY) | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 3/28/2005 | 62VAS32LAMIVUDINE (ANTI-VIRAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 3/28/2005 | 62VAS32LAMIVUDINE (ANTI-VIRAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 3/28/2005 | 62VAS32LAMIVUDINE (ANTI-VIRAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 3/28/2005 | 62VAS32LAMIVUDINE (ANTI-VIRAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 7/12/2004 | 62VAS12RIBAVIRIN (ANTI-VIRAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 7/12/2004 | 62VAS12RIBAVIRIN (ANTI-VIRAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 7/12/2004 | 62RAS11PRAZIQUANTEL (ANTI-SCHISTOSOMAL) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 7/26/2003 | 62GCS37FLUNIXIN MEGLUMINE (ANTI-INFLAMMATORY) | 72NEW VET DR | Seattle District Office (SEA-DO) |
| 4/25/2002 | 62KAS10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | 72NEW VET DR | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Matrix Laboratories (Xiamen) Ltd's FDA import refusal history?
Matrix Laboratories (Xiamen) Ltd (FEI: 3003409823) has 10 FDA import refusal record(s) in our database, spanning from 4/25/2002 to 6/19/2008.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Matrix Laboratories (Xiamen) Ltd's FEI number is 3003409823.
What types of violations has Matrix Laboratories (Xiamen) Ltd received?
Matrix Laboratories (Xiamen) Ltd has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Matrix Laboratories (Xiamen) Ltd come from?
All FDA import refusal data for Matrix Laboratories (Xiamen) Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.